146 related articles for article (PubMed ID: 10689393)
1. Improving management of type 2 diabetes mellitus: 6. Chromium.
Kuritzky L; Samraj GP; Quillen DM
Hosp Pract (1995); 2000 Feb; 35(2):113-6. PubMed ID: 10689393
[No Abstract] [Full Text] [Related]
2. Chromium, glucose tolerance, and diabetes.
Anderson RA
Biol Trace Elem Res; 1992; 32():19-24. PubMed ID: 1375056
[TBL] [Abstract][Full Text] [Related]
3. [Chromium and insulin resistance].
Kleefstra N; Bilo HJ; Bakker SJ; Houweling ST
Ned Tijdschr Geneeskd; 2004 Jan; 148(5):217-20. PubMed ID: 14983576
[TBL] [Abstract][Full Text] [Related]
4. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J
Diabetes; 1997 Nov; 46(11):1786-91. PubMed ID: 9356027
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes.
Sharma S; Agrawal RP; Choudhary M; Jain S; Goyal S; Agarwal V
J Trace Elem Med Biol; 2011 Jul; 25(3):149-53. PubMed ID: 21570271
[TBL] [Abstract][Full Text] [Related]
6. So many choices, so what's a consumer to do?: A commentary on "Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats".
Vinson JA
Free Radic Biol Med; 2007 Oct; 43(8):1121-3. PubMed ID: 17854707
[No Abstract] [Full Text] [Related]
7. Controlling blood sugar with nutrients & botanicals.
Head K; Chowka P
Adv Nurse Pract; 2003 Feb; 11(2):22. PubMed ID: 12640814
[No Abstract] [Full Text] [Related]
8. Glucose and insulin responses to dietary chromium supplements: a meta-analysis.
Althuis MD; Jordan NE; Ludington EA; Wittes JT
Am J Clin Nutr; 2002 Jul; 76(1):148-55. PubMed ID: 12081828
[TBL] [Abstract][Full Text] [Related]
9. Chromium meta-analysis.
McCarty MF
Am J Clin Nutr; 2003 Jul; 78(1):191-2; author reply 192-3. PubMed ID: 12816791
[No Abstract] [Full Text] [Related]
10. Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
Scott R; Lintott CJ; Zimmet P; Campbell L; Bowen K; Welborn T
Diabetes Res Clin Pract; 1999 Mar; 43(3):179-85. PubMed ID: 10369427
[TBL] [Abstract][Full Text] [Related]
11. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors.
Thomas VL; Gropper SS
Biol Trace Elem Res; 1996 Dec; 55(3):297-305. PubMed ID: 9096856
[TBL] [Abstract][Full Text] [Related]
12. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials.
Abdollahi M; Farshchi A; Nikfar S; Seyedifar M
J Pharm Pharm Sci; 2013; 16(1):99-114. PubMed ID: 23683609
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review.
Broadhurst CL; Domenico P
Diabetes Technol Ther; 2006 Dec; 8(6):677-87. PubMed ID: 17109600
[TBL] [Abstract][Full Text] [Related]
14. Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus.
Yin RV; Phung OJ
Nutr J; 2015 Feb; 14():14. PubMed ID: 25971249
[TBL] [Abstract][Full Text] [Related]
15. Effect of chromium supplementation on glucose tolerance and lipid profile.
Bahijri SM
Saudi Med J; 2000 Jan; 21(1):45-50. PubMed ID: 11533750
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma Endothelin-1 and glycemic control in type 2 diabetes mellitus.
Sánchez SS; Aybar MJ; Velarde MS; Prado MM; Carrizo T
Horm Metab Res; 2001 Dec; 33(12):748-51. PubMed ID: 11753762
[No Abstract] [Full Text] [Related]
17. Glycemic control in type 2 diabetes mellitus.
Quevedo SF; Westrick E
Med Health R I; 1998 Nov; 81(11):345-8. PubMed ID: 15580787
[No Abstract] [Full Text] [Related]
18. Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials.
Gaede P
Pol Arch Med Wewn; 2008 Nov; 118(11):619-21. PubMed ID: 19140564
[No Abstract] [Full Text] [Related]
19. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
20. Chromium in the prevention and control of diabetes.
Anderson RA
Diabetes Metab; 2000 Feb; 26(1):22-7. PubMed ID: 10705100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
